Samuel Sternberg, PhD

  • Professor of Biochemistry and Molecular Biophysics
Profile Headshot

Overview

Sam Sternberg is Professor of Biochemistry and Molecular Biophysics at Columbia University and an Investigator of the Howard Hughes Medical Institute. He was born and raised in Lancaster, Pennsylvania, and earned his BA in biochemistry from Columbia University, where he trained with Professor Ruben Gonzalez. He earned his PhD in chemistry from the University of California, Berkeley, under the mentorship of Professor Jennifer Doudna. He was awarded graduate student fellowships from the National Science Foundation and the Department of Defense, and received the Scaringe Award from the RNA Society and the Harold Weintraub Graduate Student Award from the Fred Hutchinson Cancer Research Center. After a brief postdoc and book writing stint, Sam spent a year working at Caribou Biosciences, a Bay Area biotech start-up focusing on genome engineering applications, as a Scientist and Group Leader of Technology Development. He started his independent career in the Department of Biochemistry and Molecular Biophysics at Columbia in February, 2018.

The Sternberg laboratory investigates the fundamental biology and biotechnology of mobile genetic elements and bacterial immune systems. The lab pioneered the discovery of CRISPR-associated transposases, which perform RNA-guided DNA integration, and has developed these systems for targeted gene insertion in bacterial and human cells. More recently, the lab has uncovered diverse antiviral reverse transcriptase systems that synthesize unusual DNA products — including de novo genes and protein-primed DNA polymers — to defend bacteria against phage infection. The group has also discovered transposon-derived RNA-guided proteins that have been repurposed during evolution as transcription factors and other regulators of gene expression. The laboratory combines biochemistry, genetics, molecular biology, biophysics, and structural biology to reveal new mechanisms of genome defense, gene regulation, and genome evolution, with an eye toward translating mechanistic discoveries into new genome-engineering technologies.

Sam is committed to being a supportive mentor and effective lab manager, and to nurturing a collaborative research environment. He has closely mentored over two dozen undergraduate and graduate students, and has participated in numerous mentorship programs, including Student Mentoring and Research Teams (SMART) and Howard Hughes Medical Institute’s Exceptional Research Opportunities Program (EXROP) at Berkeley. The desire to work with students in the lab was a major driver of Sam’s decision to transition from industry back to academia.

Outside of the lab, Sam is a passionate advocate for science communication and science outreach. He regularly presents to public audiences on the discovery of CRISPR–Cas immune systems and the ensuing gene-editing revolution, including a TEDMED talk in 2015, and has co-authored a pop-sci book with Jennifer Doudna on the same topic, titled A Crack in Creation: Gene Editing and the Unthinkable Power to Control Evolution. Their book received enthusiastic reviews from The Wall Street Journal and The Guardian, among other outlets, and was a finalist for the Los Angeles Times Book Prize. The New York Review of Books called it “required reading for every concerned citizen.”

Email

shs2107@cumc.columbia.edu
shsternberg@gmail.com

Academic Appointments

  • Professor of Biochemistry and Molecular Biophysics

Credentials & Experience

Education & Training

  • BA, 2007 Biochemistry, Columbia University
  • PhD, 2014 Chemistry, University of California, Berkeley

Honors & Awards

  • 2024-Present — Investigator, Howard Hughes Medical Institute
  • 2026 — Finalist, Blavatnik National Awards for Young Scientists in Life Sciences
  • 2025 — Finalist, Blavatnik National Awards for Young Scientists in Life Sciences
  • 2025 — RNA Society Early-Career Research Award
  • 2024–2028 — Mallinckrodt Scholar Award
  • 2024 — Amgen Young Investigator Award
  • 2023–2028 — NSF CAREER Award
  • 2022 — Harold and Golden Lamport Award for Excellence in Basic Science Research
  • 2021–2026 — Irma T. Hirschl and Monique Weill-Caulier Research Award
  • 2020–2025 — NIH Director’s New Innovator Award
  • 2020–2025 — Pew Scholarship in the Biomedical Sciences
  • 2020–2022 — Alfred P. Sloan Research Fellowship in Chemistry

Research

Mobile genetic elements, bacterial immunity, and genome engineering

The Sternberg laboratory studies how mobile genetic elements and bacterial immune systems generate biological innovation. We combine biochemistry, genetics, molecular biology, biophysics, and structural biology to discover molecular machines that control DNA, RNA, and gene expression — and to harness their activities for genome engineering.

A major focus of the lab is the biology of bacterial reverse transcriptases. Our work has revealed remarkable antiviral systems that synthesize DNA in response to phage infection, including reverse transcriptases that perform de novo gene synthesis, generate protein-primed DNA polymers, or coordinate the production of double-stranded DNA. These findings are uncovering unexpected roles for reverse transcription in innate immunity and illuminating the evolutionary origins of other DNA-synthesis pathways.

The lab also studies CRISPR-associated transposases (CASTs), which couple RNA-guided DNA targeting to programmable DNA integration. We discovered that these systems direct RNA-guided transposition, defined core mechanisms governing target-site selection and integration fidelity, and engineered CASTs for targeted gene insertion in bacterial and human cells without double-strand breaks. Related work explores how transposon-encoded RNA-guided proteins have been repurposed as transcription factors, how mobile elements use guide RNAs to promote their own spread, and how phages can co-opt RNA-guided regulation to remodel bacterial physiology.

Together, these studies reveal how mobile elements and immune systems continually invent new molecular functions, while providing starting points for technologies that precisely manipulate genomes and gene expression.

Please visit the Sternberg Laboratory website at www.sternberglab.org.

Selected Publications

  1. Wang, M.*, Yoneyama, K.* et al. “Coordinated synthesis of double-stranded DNA by a dual reverse transcriptase immune system.” Cell 189 (2026), 4997–5011.
  2. Walker, M.W.G.*, Richard, E.* et al. “Temperate phages enhance host fitness via RNA-guided flagellar remodeling.” Nature Microbiology 11 (2026): 1815–1832.
  3. Hoffmann, F.T. et al. “Exapted CRISPR-Cas12f homologs drive RNA-guided transcription.” Nature 653 (2026): 277–287.
  4. Xiao, R.*, Hoffmann, F.T.*, et al. “Structural basis of RNA-guided transcription by a dCas12f-σE-RNAP complex.” Nature 653 (2026): 288–296.
  5. Tang, S.*, Žedaveinytė, R.*, Burman, N.*, Pandey, S.* et al. “Protein-primed homopolymer synthesis by an antiviral reverse transcriptase.” Nature 643 (2025): 1352–1362.
  6. Witte, I.P.*, Lampe, G.D.*, Eitzinger, S.* et al. “Programmable gene insertion in human cells with a laboratory-evolved CRISPR-associated transposase.” Science 388 (2025): eadt5199.
  7. Tang, S. et al. “De novo gene synthesis by an antiviral reverse transcriptase.” Science 386 (2024): eadq0876.
  8. Wiegand, T. et al. “TnpB homologs exapted from transposons are RNA-guided transcription factors.” Nature 631 (2024): 439–448.
  9. Lampe, G.D.*, King, R.T.* et al. “Targeted DNA integration in human cells without double-strand breaks using CRISPR-associated transposases.” Nature Biotechnology 42 (2024): 87–98.
  10. Klompe, S.E. et al., “Transposon-encoded CRISPR–Cas systems direct RNA-guided DNA integration.” Nature 571 (2019): 219–225.

*Equal contribution, where indicated.

Back to top